Curcumin (Synthetic), a phenolic pigment originally isolated from Curcuma longa (tumeric) has reported antioxident, anticancer and anti-inflammatory actvities as noted in multiple in vitro studies. A study investigating the effects of curcumin on reported inflammatory mediators in inflammatory bowel disease on colonic myofibroblasts obtained ex vivo reported that a dose-dependent suppression of matrix metalloproteinase-3 (MMP-3) occured. Additional studies report that Curcumin is able to suppress NF-κB, COX-1, COX-2 and TNF-α. Noted in research studies to upregulate PPARγ, p53 and Nrf2. Curcumin (Synthetic) is an inhibitor of 5-LO, Cox-2, CREB Binding Protein, GST, IKK, JNK, NF kappa B, NOS2, NQO1 and p300. Curcumin has been shown to modify histones. In one study, exposure of MCF7 cells to curcumin resulted in increased global levels of acetylated H3K18 and H4K16.
1. Asai, A. and Miyazawa, T. 2001. J. Nutr. 131: 2932-2935. PMID: 11694621
2. Hanai, H. and Sugimoto, K. 2009. Curr. Pharm. Des. 15: 2087-2094. PMID: 19519446
3. Epstein, J., et al. 2010. Br. J. Nutr. 103: 824-832. PMID: 19878610
4. Shehzad, A., et al. 2011. Eur J Nutr. [Epub ahead of print]. PMID: 21442412
See how others have used Curcumin (Synthetic). Click on the entry to view the PubMed entry .
PMID: # 29740418 Simpson, S. et al. 2018. Front Microbiol. 9: 788.
PMID: # 22847000 Narayanan, A. et al. 2012. The Journal of biological chemistry. 287: 33198-214.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.